|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 6 |
| 1.1 List of Tables | 6 | 1 |
| 1.2 List of Figures | 7 | 1 |
| 2 Introduction | 8 | 1 |
| 2.1 What Is This Report About? | 8 | 1 |
| 3 Definitions of Markets Covered in This Report | 9 | 2 |
| 3.1 Drug delivery devices | 9 | 1 |
| 3.2 Inhalation Systems | 9 | 1 |
| 3.2.1 Metered Dose Inhaler | 9 | 1 |
| 3.2.2 Dry powder inhaler | 9 | 1 |
| 3.3 Infusion Systems | 9 | 1 |
| 3.3.1 Infusion pumps | 9 | 1 |
| 3.3.2 Syringe pumps | 9 | 1 |
| 3.3.3 Disposable Infusion sets | 10 | 1 |
| 4 Healthcare Sector Review | 11 | 3 |
| 5 Regulation System | 14 | 2 |
| 5.1 Documents Required | 14 | 1 |
| 5.2 Labeling Requirements | 15 | 1 |
| 6 Pricing and Reimbursement | 16 | 1 |
| 7 Distribution Structure | 17 | 1 |
| 8 Drug Delivery Devices In Argentina | 18 | 8 |
| 8.1 Drug Delivery Devices, Argentina, Overall Revenue ($ mn), 2000-2015 | 18 | 4 |
| 8.2 Drug Delivery Devices, Argentina, Category Volume (Units), 2000-2015 | 22 | 3 |
| 8.3 Drug Delivery Devices, Argentina, Company Share (2007-2008) | 25 | 1 |
| 9 Infusion Systems In Argentina | 26 | 6 |
| 9.1 Infusion Systems Overall Revenue (2000-2015) | 26 | 2 |
| 9.2 Infusion Systems Overall Volume (2000-2015) | 28 | 1 |
| 9.3 Infusion Systems Average Price (2000-2015) | 29 | 1 |
| 9.4 Infusion Systems Distribution Share (2007-2008) | 30 | 1 |
| 9.5 Infusion Systems, Argentina, Company Share (2007-2008) | 31 | 1 |
| 10 Inhalation Systems In Argentina | 32 | 7 |
| 10.1 Inhalation Systems Overall Revenue (2000-2015) | 32 | 2 |
| 10.2 Inhalation Systems Overall Volume (2000-2015) | 34 | 2 |
| 10.3 Inhalation Systems Average Price (2000-2015) | 36 | 1 |
| 10.4 Inhalation Systems Distribution Share (2007-2008) | 37 | 1 |
| 10.5 Inhalation Systems, Argentina, Company Share (2007-2008) | 38 | 1 |
| 11 Overview of Key Companies in Argentina Drug Delivery Devices Market | 39 | 12 |
| 11.1 AstraZeneca PLC | 39 | 1 |
| 11.1.1 Company Overview | 39 | 1 |
| 11.2 Boehringer Ingelheim GmbH | 39 | 1 |
| 11.2.1 Company Overview | 39 | 1 |
| 11.3 Baxter International Inc. | 40 | 1 |
| 11.3.1 Company Overview | 40 | 1 |
| 11.4.1 Company Overview | 40 | 1 |
| 11.5 Terumo Corporation | 41 | 1 |
| 11.5.1 Company Overview | 41 | 1 |
| 11.5.2 Terumo Corporation Pipeline Products | 41 | 1 |
| 11.5.2.1 Terumo Corporation Pipeline Products By Equipment Type | 41 | 1 |
| 11.5.2.2 Terumo Corporation Pipeline Products By Development Stage | 41 | 1 |
| 11.5.2.3 Terumo Corporation Pipeline Products By Therapy Area | 42 | 1 |
| 11.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials | 42 | 1 |
| 11.5.2.5 Terumo Corporation Pipeline Products By News Summary | 43 | 1 |
| 11.6 Cardinal Health, Inc. | 44 | 1 |
| 11.6.1 Company Overview | 44 | 1 |
| 11.7 GlaxoSmithKline plc | 45 | 1 |
| 11.7.1 Company Overview | 45 | 1 |
| 11.8 B. Braun Melsungen AG | 46 | 1 |
| 11.8.1 Company Overview | 46 | 1 |
| 11.9 Smiths Medical | 46 | 1 |
| 11.9.1 Company Overview | 46 | 1 |
| 11.10 Fresenius Kabi AG | 47 | 1 |
| 11.10.1 Company Overview | 47 | 1 |
| 11.11 Consort Medical plc | 48 | 1 |
| 11.11.1 Company Overview | 48 | 1 |
| 11.11.2 Consort Medical plc Pipeline Products | 48 | 1 |
| 11.11.2.1 Bespak plc Pipeline Products By Equipment Type | 48 | 1 |
| 11.11.2.2 Bespak plc Pipeline Products By Development Stage | 48 | 1 |
| 11.11.2.3 Bespak plc Pipeline Products By Therapy Area | 49 | 1 |
| 11.12 Hospira, Inc. | 50 | 1 |
| 12 Appendix | 51 | 5 |
| 12.1 Global Markets Direct Research Methodology | 51 | 1 |
| 12.2 Secondary Research | 52 | 1 |
| 12.3 Primary Research | 52 | 1 |
| 12.4 Models | 53 | 1 |
| 12.5 Forecasts | 53 | 1 |
| 12.6 Expert Panel Validation | 53 | 1 |
| 12.7 Currency Conversion | 54 | 1 |
| 12.8 Contact Us | 55 | 1 |
| 12.9 Disclaimer | 55 | 1 |